Tiziana Life Sciences Ltd
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tiziana Life Sciences Ltd generated cash of -$15,698,000, which is more than the previous year. Cash used in financing activities reached the amount of $40,000 last year. Net change in cash is therefore -$16,939,000.
Cash Flow
| 2014 | -3.39M | 99.61K | 6.81M |
|---|---|---|---|
| 2015 | -5.51M | 0 | 12.14M |
| 2016 | -6.30M | -310.91K | 1.43M |
| 2017 | -5.85M | -1K | 1.19M |
| 2018 | -4.33M | -788 | 9.55M |
| 2019 | -5.32M | -3K | 1.31M |
| 2020 | -12.67M | -134.91K | 78.30M |
| 2021 | -21.76M | 130K | -23K |
| 2022 | -19.61M | -3.99M | -55K |
| 2023 | -15.69M | -1.25M | 40K |
TLSA Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 18.12M | 42.18M | 65.82M | 208.51K | 4.16M | 60.90K | 4.70M | 10.98M | 2.26M | 0 |
Operating activities | ||||||||||
Net income | -17.24M | -15.39M | -26.65M | -30.07M | -7.30M | -9.45M | -6.77M | -8.89M | -8.63M | -5.55M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 96K | 51K | 141K | 96.76K | 198K | 15.22K | 11K | 9.87K | 0 | 0 |
Stock-based compensation expense | 1.73M | -1.41M | 5.17M | 5.09M | 0 | 801.94K | 0 | 1.25M | 0 | 510.52K |
| Deferred income tax benefit | 1.73M | -1.41M | 5.17M | 5.09M | 0 | 801.94K | 0 | 1.25M | 0 | 510.52K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.52M | -156K | 428K | -466.77K | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | -428K | 466.77K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | -1.00M | -685K | -1.03M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -15.69M | -19.61M | -21.76M | -12.67M | -5.32M | -4.33M | -5.85M | -6.30M | -5.51M | -3.39M |
Investing activities | ||||||||||
Purchases Of Investments | -1.25M | -3.99M | 0 | -120K | 0 | 0 | 0 | -267.73K | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -22K | -134.91K | -3K | 0 | -1K | -43.18K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 99.61K |
Cash generated by investing activities | -1.25M | -3.99M | 130K | -134.91K | -3K | -788 | -1K | -310.91K | 0 | 99.61K |
Financing activities | ||||||||||
Common Stock Issued | 24K | 0 | 129K | 78.06M | 1.47M | 10.87M | 1.19M | 558.91K | 2.63M | 3.11M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -119K | -55K | -152K | -294.37K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 40K | -55K | -23K | 78.30M | 1.31M | 9.55M | 1.19M | 1.43M | 12.14M | 6.81M |
Net Change In Cash | -16.93M | -24.06M | -23.63M | 65.50M | -4.01M | 5.22M | -4.65M | -5.18M | 6.63M | 3.52M |
Cash at end of period | 1.18M | 18.12M | 42.18M | 65.71M | 153K | 5.28M | 48K | 5.80M | 8.90M | 3.52M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |